Mark L. Portnoy - 24 May 2021 Form 4 Insider Report for CRYO CELL INTERNATIONAL INC (CCEL)

Role
Co-CEO, Director
Signature
/s/ Mark Portnoy
Issuer symbol
CCEL
Transactions as of
24 May 2021
Net transactions value
$0
Form type
4
Filing time
26 May 2021, 17:00:38 UTC
Next filing
26 Aug 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CCEL Common Stock Options Exercise $344,000 +200,000 +41% $1.72 687,514 24 May 2021 Direct
transaction CCEL Common Stock Options Exercise $93,334 +32,184 +4.7% $2.90 719,698 24 May 2021 Direct
holding CCEL Common Stock 42,266 24 May 2021 By 401K
holding CCEL Common Stock 71,529 24 May 2021 By Partnership F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CCEL Stock Option Options Exercise $344,000 -200,000 -100% $1.72 0 24 May 2021 Common Stock 200,000 $1.72 Direct
transaction CCEL Stock Option Options Exercise $93,334 -32,184 -32% $2.90 67,816 24 May 2021 Common Stock 100,000 $2.90 Direct
holding CCEL Stock Option 59,459 24 May 2021 Common Stock 59,459 $3.14 Direct
holding CCEL Stock Option 20,000 24 May 2021 Common Stock 20,000 $7.92 Direct
holding CCEL Stock Option 22,222 24 May 2021 Common Stock 22,222 $7.53 Direct
holding CCEL Stock Option 20,000 24 May 2021 Common Stock 20,000 $7.28 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares of Common Stock held by Capital Asset Fund #1 Limited Partnership, as to which Mark L. Portnoy may be deemed the beneficial owner as its general partner.
F2 Stock options will vest 1/3 on the date of grant, 1/3 on December 1, 2020 and 1/3 on December 1, 2021.